Food and Drug Administration Finalizes Guidances to Accelerate the Development of Reliable and Beneficial Next Generation Sequencing-based Tests

Food and Drug Administration Finalizes Guidances to Accelerate the Development of Reliable and Beneficial Next Generation Sequencing-based Tests

Link

The agency is leveraging new tools and policies to advance the creation of innovative genetic and genomic-based tests and help ensure the validity of their results



(April 12, 2018) - - The U.S. Food and Drug Administration (FDA) today finalized two guidances to drive the efficient development of a novel technology that scans a person’s DNA to diagnose genetic diseases, which are usually hereditary, and guide...

Massachusetts General Hospital-led Team Identifies Gene Mutations Behind Lack of a Nose

Alterations in same gene previously associated with rare form of muscular dystrophy



February 27, 2017


Boston, MA - - (February 10, 2017) - - Researchers from Massachusetts General Hospital (MGH) led a large, international research team that has identified gene mutations associated with a rare congenital condition involving the absence of a nose and often...